MIRM
Mirum Pharmaceuticals, Inc. Common StockData: 2026-11-11
Quick Stats
Nov 11, 202639.9
AI Score
AVOID NEW MONEY0.7
Volume Ratio
TBA
Next Earnings
18
+ve Days (30d)
12
-ve Days (30d)
MIRM Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
MIRM Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
MIRM Options - Sort by Max open Interest (near term)
12th November 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MIRM Daily Out of Money Options - Sort by Max open Interest (near term)
12th November 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MIRM Daily In the Money Options - Sort by Max open Interest (near term)
12th November 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MIRM Most Active Options by Volume(near term)
12th November 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MIRM Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MIRM Stock Summary
Last updated Nov 11, 2026
MIRM is currently trading at $94.61, positioned below its 200-day moving average of $98.49, suggesting bearish momentum. The stock has a 52-week range of $63.232 to $130.
Technical Analysis: The 50-day moving average stands at $89.05, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 61.833, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.059, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates MIRM at 39.9/100 with a AVOID NEW MONEY recommendation.
MIRM (Mirum Pharmaceuticals, Inc. Common Stock) Indicators
Last updated Nov 11, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 61.833 |
| CMF (20) | 0.059 |
| ROC (10) | 10.255 |
| ADX (14) | 26.423 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 2.061 |
| AROONOSC (14) | 64.286 |
| WILLAMS %R (14) | -23.278 |
| MFI (14) | 63.961 |
MIRM Candlestick Patterns
No validated candlestick patterns fired for MIRM in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Mirum Pharmaceuticals, Inc. Common Stock is above the 50 Day SMA but below the 200 Day SMA — short-term strength within a longer-term downtrend (Mixed).
MIRM Moving Averages Analysis
Mirum Pharmaceuticals, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Nov 11, 2026
MIRM (Mirum Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Nov 11, 2026
| Days | MA |
|---|---|
| 10 | 91.06 |
| 20 | 87.1 |
| 30 | 85.44 |
| 50 | 89.05 |
| 100 | 99.48 |
| 200 | 98.49 |
MIRM Fundamental Analysis
| P/E (Forward) | 196.0784 |
| P/E (Trailing) | -- |
| Market Cap ($) | 6.2 billion |
| Earnings/Share ($) | -14.66 |
| Net Profit Margin (%) | -1.3475 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -15.67 |
| EPS Estimate Next Year ($) | 0.32 |
| WallStreet Target Price ($) | 156.92 |
| Most Recent Quarter |
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.